Table 1.
Predictors | Beta | SE | p‐Value | 95% CI | Stand. Beta |
---|---|---|---|---|---|
Model 1 | [18F]altanserin, n = 139 | ||||
Neocortex 2A binding | −2.54 | 3.75 | 0.50 | −9.95, 4.88 | −0.068 |
Age | −0.43 | 0.11 | 0.000078 | −0.64, −0.22 | −0.40 |
Sex | −4.32 | 3.14 | 0.17 | −10.53, 1.89 | −0.11 |
Model 2 | [11C]‐Cimbi‐36, n = 28 | ||||
Neocortex 2A binding | 9.03 | 29.72 | 0.76 | −52.31, 70.37 | 0.097 |
Age | 1.02 | 0.26 | 0.31 | −0.99, 3.03 | 0.26 |
Sex | −8.81 | 10.36 | 0.40 | −30.20, 12.57 | −0.22 |
Model 3 | Combined [18F]altanserin and [11C]‐Cimbi‐36, n = 159 | ||||
Neocortex 2A binding | −2.92 | 3.50 | 0.40 | −9.79, 3.94 | −0.07 |
Age | −0.42 | 0.10 | 0.000020 | −0.62, −0.23 | −0.38 |
Radioligand | −9.55 | 4.46 | 0.032 | −18.30, −0.81 | −0.19 |
Sex | −5.24 | 3.06 | 0.087 | −11.24, 0.77 | −0.14 |
Note. Parameters from the models used to investigate associations between neocortex 5‐HT2AR binding and trait Openness, including the combined model with both radioligands, [18F]altanserin and [11C]‐Cimbi‐36, in Model 3. Combined analyses included 167 observations (eight individuals scanned two times). Sex parameter estimates reflect difference in trait Openness relative to female. SE = standard error, 95% CI = 95% confidence interval, Stand. Beta = standardized regression coefficient.